Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

IDEXX Laboratories logoIDEXX Laboratories IDXX

The company said Chief Financial Officer Brian P. McKeon will retire on June 1, 2025 and will step down as Chief Financial Officer and Treasurer on March 1, 2025. He will then serve as Executive Vice President and Special Advisor through June 1.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary

  1. The company said Chief Financial Officer Brian P. McKeon will retire on June 1, 2025 and will step down as Chief Financial Officer and Treasurer on March 1, 2025. He will then serve as Executive Vice President and Special Advisor through June 1.

  2. The company said its board appointed Andrew Emerson, currently Senior Vice President, Corporate and CAG Finance, as Executive Vice President, Chief Financial Officer and Treasurer, effective March 1, 2025. He will serve as the company's principal financial officer and principal accounting officer. The appointment was made on November 20, 2024.

  3. The company said Emerson's annual base salary will be $550,000, and his fiscal 2025 target cash bonus will be 75% of base salary. He will also be eligible for benefits under a change in control agreement with substantially the same terms as McKeon's.

  4. The company said oversight responsibility for McKeon's Water, Livestock, Poultry and Dairy and OPTI Medical businesses will transfer to Michael Lane effective January 1, 2025. Emerson has led the finance organization for CAG since joining the company in November 2015, and has also led the corporate finance function since March 2020.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

CFO transition and McKeon retirement timing

The company said Chief Financial Officer Brian P. McKeon will retire on June 1, 2025 and will step down as Chief Financial Officer and Treasurer on March 1, 2025. He will then serve as Executive Vice President and Special Advisor through June 1.

Source · Based on the filing body and exhibits

Andrew Emerson named successor CFO

The company said its board appointed Andrew Emerson, currently Senior Vice President, Corporate and CAG Finance, as Executive Vice President, Chief Financial Officer and Treasurer, effective March 1, 2025. He will serve as the company's principal financial officer and principal accounting officer. The appointment was made on November 20, 2024.

Source · Based on the filing body and exhibits

Emerson pay and change in control terms

The company said Emerson's annual base salary will be $550,000, and his fiscal 2025 target cash bonus will be 75% of base salary. He will also be eligible for benefits under a change in control agreement with substantially the same terms as McKeon's.

Source · Based on the filing body and exhibits

McKeon duties transferred and Emerson background

The company said oversight responsibility for McKeon's Water, Livestock, Poultry and Dairy and OPTI Medical businesses will transfer to Michael Lane effective January 1, 2025. Emerson has led the finance organization for CAG since joining the company in November 2015, and has also led the corporate finance function since March 2020.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗
Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.